Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Prescription costs rise more than six times when patients reach 65 says study of five million people

13.03.2008
Prescribing costs increase dramatically when people reach 65, according to a detailed analysis of more than five million patients published in the March issue of the British Journal of Clinical Pharmacology.

Average costs were six-and-a-half times higher than for people under 65 and 16 times higher than for children under four.

When researchers from the Faculty of Pharmacy at the University of Barcelona looked at the primary care records of 5.47 million patients in Catalonia, they found that just under three-quarters had been prescribed at least one drug and that women were 23 per cent more likely to receive a prescription.

But the outstanding finding was the significant cost differences based on the ages of the patients. When the researchers looked at the average number of drugs that patients were prescribed, people over 75 had almost eight times as many prescriptions as children under four years of age.

And the cost differentials for people over 65 were much higher than the four-and-a half times’ increase reported by a previous study in 1993.

“This is probably due to a number of factors” explains lead researcher Professor Eduardo L Marino from the Faculty’s Clinical Pharmacy and Pharmacotherapy Unit. “Our population is progressively ageing, we are better at detecting problems than 15 years ago and more expensive drugs are being developed.”

Being able to predict prescribing costs is very important, he adds, especially when there are so many demands and pressures on healthcare budgets.

“We looked at prescribing by gender, breaking down patients into ten age categories and analysing their use of 15 different categories of drugs” he says.

“This enabled us to build up a very clear picture of what sort of drugs people were taking, depending on their age and gender.”

Other key findings of the study included:

•Overall prescribing rates were highest in children under four (85 per cent of boys and 81 per cent of girls) and adults over 54.

•The only categories not to reach 100 per cent prescribing rates over the age of 54 were men aged 55 to 64 (85 per cent) and men who were 85 years plus (91 per cent).

•The most common prescriptions for children under four were for pain killers and fever-reducing drugs, followed by cough suppressants.

•The authors found a higher use of antibiotics in children under 14 than reported in other studies and suggested that this could indicate that doctors were over prescribing them.

•Female patients were prescribed more drugs than men (81 per cent compared to 68 per cent), except in children under 15 where the percentage was higher in males.

•Women were more than twice as likely to use antidepressants as men (12 per cent versus five per cent) and this was most notable in the 35 to 44 age group.

“Our study underlines the significantly higher costs of prescribing to older patients and this information is vital at a time when we face a progressively ageing population” concludes co-author Eladio Fernandez-Liz of the Institut Catala de la Salut, who analysed the data. “It also provides a detailed breakdown of the drugs most commonly prescribed in ten age groups and by gender.

“By combining this information with details of the local patient population, our study can help healthcare providers to predict future prescription costs and look at specific health interventions in those age groups with the heaviest prescription drug use.”

Annette Whibley | alfa
Further information:
http://www.blackwell-synergy.com/loi/bcp

More articles from Studies and Analyses:

nachricht Smart Data Transformation – Surfing the Big Wave
02.12.2016 | Fraunhofer-Institut für Angewandte Informationstechnik FIT

nachricht Climate change could outpace EPA Lake Champlain protections
18.11.2016 | University of Vermont

All articles from Studies and Analyses >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Significantly more productivity in USP lasers

In recent years, lasers with ultrashort pulses (USP) down to the femtosecond range have become established on an industrial scale. They could advance some applications with the much-lauded “cold ablation” – if that meant they would then achieve more throughput. A new generation of process engineering that will address this issue in particular will be discussed at the “4th UKP Workshop – Ultrafast Laser Technology” in April 2017.

Even back in the 1990s, scientists were comparing materials processing with nanosecond, picosecond and femtosesecond pulses. The result was surprising:...

Im Focus: Shape matters when light meets atom

Mapping the interaction of a single atom with a single photon may inform design of quantum devices

Have you ever wondered how you see the world? Vision is about photons of light, which are packets of energy, interacting with the atoms or molecules in what...

Im Focus: Novel silicon etching technique crafts 3-D gradient refractive index micro-optics

A multi-institutional research collaboration has created a novel approach for fabricating three-dimensional micro-optics through the shape-defined formation of porous silicon (PSi), with broad impacts in integrated optoelectronics, imaging, and photovoltaics.

Working with colleagues at Stanford and The Dow Chemical Company, researchers at the University of Illinois at Urbana-Champaign fabricated 3-D birefringent...

Im Focus: Quantum Particles Form Droplets

In experiments with magnetic atoms conducted at extremely low temperatures, scientists have demonstrated a unique phase of matter: The atoms form a new type of quantum liquid or quantum droplet state. These so called quantum droplets may preserve their form in absence of external confinement because of quantum effects. The joint team of experimental physicists from Innsbruck and theoretical physicists from Hannover report on their findings in the journal Physical Review X.

“Our Quantum droplets are in the gas phase but they still drop like a rock,” explains experimental physicist Francesca Ferlaino when talking about the...

Im Focus: MADMAX: Max Planck Institute for Physics takes up axion research

The Max Planck Institute for Physics (MPP) is opening up a new research field. A workshop from November 21 - 22, 2016 will mark the start of activities for an innovative axion experiment. Axions are still only purely hypothetical particles. Their detection could solve two fundamental problems in particle physics: What dark matter consists of and why it has not yet been possible to directly observe a CP violation for the strong interaction.

The “MADMAX” project is the MPP’s commitment to axion research. Axions are so far only a theoretical prediction and are difficult to detect: on the one hand,...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

ICTM Conference 2017: Production technology for turbomachine manufacturing of the future

16.11.2016 | Event News

Innovation Day Laser Technology – Laser Additive Manufacturing

01.11.2016 | Event News

#IC2S2: When Social Science meets Computer Science - GESIS will host the IC2S2 conference 2017

14.10.2016 | Event News

 
Latest News

Closing the carbon loop

08.12.2016 | Life Sciences

Applicability of dynamic facilitation theory to binary hard disk systems

08.12.2016 | Physics and Astronomy

Scientists track chemical and structural evolution of catalytic nanoparticles in 3-D

08.12.2016 | Materials Sciences

VideoLinks
B2B-VideoLinks
More VideoLinks >>>